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Review question/objective 
Are intermittent fasting interventions an effective treatment for overweight and obesity in adults, when 
compared to usual care treatment (continuous daily energy restriction – reduced calorie diet) or no 
treatment (ad libitum diet)? 
Background 
Overweight and obesity (classified as Body Mass Index (BMI) of greater than or equal to 25 and 30 
respectively), is a global public health concern, with more than 1.9 billion overweight adults in 2014 
(over 600 million of whom are obese), resulting in more deaths worldwide than underweight. 1 A raised 
BMI in adulthood is associated with an increased risk of developing a number of chronic diseases which 
include diabetes, cardiovascular disease, muscular skeletal disorders and some cancers.1 In addition to 
this substantial impact on individual health and well being, there are also significant wider costs, for 
example in England the direct cost to the national health service for treating overweight, obesity and 
associated morbidity is estimated at over five billion pounds, with costs to the wider economy estimated 
at 27 billion.2, 3 Therefore effective weight management is essential. 
As overweight and obesity results from an accumulation of excess body fat, arising from an energy 
imbalance: consuming more energy (kcal) than are expended, the majority of weight management 
approaches centre around behaviours to address this imbalance i.e. reducing energy intake through 
caloric restriction and increasing energy expenditure through physical activity. However, the aetiology 
of overweight and obesity is highly complex, involving an interplay of biological, psychological, societal 
and environmental drivers.3 Consequently, effective weight management is challenging, and whilst 
there remains a plethora of available weight loss programmes, not all are comprehensively evaluated 
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and compared, and many weight loss attempts result in weight regain and poor long term results.4 It is 
therefore vitally important to review the effectiveness of all new approaches, to support an evidence 
based approach to weight management. 
Intermittent fasting (IF), also known as alternate day fasting (ADF), periodic fasting or intermittent 
energy restriction (IER) is a relatively new dietary approach to weight management, that involves 
interspersing normal daily caloric intake with a short period of severe calorie restriction/fasting. In terms 
of the possible underlying biological benefits of intermittent fasting, there is some evidence, 
predominantly from animal studies, to demonstrate beneficial effects on weight loss and 
cardio-metabolic risk factors. Whilst the underpinning mechanistic evidence is limited,6 there is some 
evidence to suggest that the benefits may be explained mechanistically through fat utilisation and 
nutritional stress (which can at least in part result in cellular repairs and functional optimisation)7 that 
can result from fasting. However current NICE guidance on the treatment of adult obesity 5 does not 
recommend the routine use of very low calorie diets (VLCD) (defined as a hypocaloric diet of 800 or less 
kcal/day) for the treatment of adult obesity. NICE state that this approach should only be recommended 
if there is a clinical rationale for rapid weight loss and must be nutritionally complete, part of a 
multi-component weight management strategy, including ongoing support, and should be undertaken 
for a maximum of 12 weeks (followed continuously or intermittently). Furthermore, the British Dietetic 
Association8 raise concern that rapid weight loss associated with fasting may largely be due to loss of 
water and glycogen rather than fat, and may result in fatigue, dizziness and low energy levels. 
Essentially IF involves the intermittent use of a VLCD, and there remain questions about the side effects 
of this approach, whether there is an optimal fasting pattern or calorie limit, and how sustainable it is for 
long term weight management. 
 
Intermittent fasting has recently gained much popularity following significant media attention. In the UK 
this dietary approach reached mainstream after a BBC Horizon documentary aired in August 2012, 
featured an IF approach called the 5:2 diet, which involves 5 days of regular eating patterns 
interchanged with 2 days of fasting (max 500kcal for women and 600kcal for men). However other IF 
patterns are used such as alternate day fasting.6 Despite the recent popularity of intermittent fasting9 
and associated weight loss claims,10 the supporting evidence base in humans remains small and there 
is only one published systematic review7 examining the health benefits of this approach, however the 
aim of this review was to examine the impact on wider health benefits, not specifically  as a treatment 
approach for overweight and obesity, it also failed to provide a detailed methodology, and any meta 
analyses. . This review will address these gaps in the evidence base. 
Inclusion criteria 
Types of participants 
This review will consider studies that include free-living (not hospitalised) male and female adults aged 
18 years and over (adults of any age will be included, however age will be considered as a potential 
moderator) who are overweight or obese (i.e. have a BMI  greater than or equal to 25 or 30) 
Participants will be excluded if they have secondary or syndromic forms of obesity; or are diabetic, 
undergoing bariatric surgery, pregnant or breast feeding, taking medication associated with weight loss 
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(e.g. orlistat, metformin) or weight gain (e.g. steroids, antipsychotics). 
Types of intervention(s)/phenomena of interest 
This review will consider studies that evaluate intermittent fasting interventions, defined as consumption 
of 800* kcal or less on at least one day, but no more than 6 days in a calendar week, that follow 
participants for at least 12 calendar weeks from the start of the intervention. 
*as there is no accepted formal definition of 'fasting' - the NICE upper limit for a very low calorie diet will 
be used in this review 5. 
Types of comparators 
Interventions will be compared to control (no intervention) or usual care (which is likely to consistent of 
advice to continuously follow a reduced calorie diet, which is usually around 25% of recommended 
energy intake). 
 
Types of outcomes 
Primary outcome: any objective, validated measure of adiposity: measured (not self reported) body 
mass; body mass index; waist circumference; skin fold thickness; bio-impedance; hydrostatic or 
BodPod measures; dual X-ray absorptiometry (DXA) or magnetic resonance imaging (MRI) scans. 
Secondary outcomes: adverse events; quality of life; disease risk markers (e.g. blood glucose, 
cholesterol, blood pressure); diet; and physical activity. 
Types of studies 
This review will only consider randomised or pseudo randomised controlled trials. 
 
Search strategy 
The search strategy aims to find both published and unpublished studies. A three-step search strategy 
will be utilised in this review. An initial limited search of MEDLINE and CINAHL will be undertaken 
followed by analysis of the text words contained in the title and abstract, and of the index terms used to 
describe the relevant articles. A second search using all identified keywords and index terms will then 
be undertaken across all included databases. Thirdly, the reference list of all identified reports and 
articles will be searched for additional studies. Studies in English language, published since database 
inception will be considered for inclusion in this review. 
The databases to be searched include: 
Medline via OVID Host 
Embase via OVID 
Cinahl via EBSCO Host 
Central 
The search for unpublished studies will include: 
JBI Database of Systematic Reviews & Implementation Reports 
Page 4 




Initial keywords to be used will be intermittent fasting or periodic fasting, alternate day fasting or 
intermittent calorie restriction, and overweight or obesity. A provisional full search strategy (to be 
confirmed following the initial search) is presented in appendix III. 
Assessment of methodological quality 
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity 
prior to inclusion in the review using standardised critical appraisal instruments from the Joanna Briggs 
Institute Meta Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I). 
Any disagreements that arise between the reviewers will be resolved through discussion, or with a third 
reviewer. 
Data collection 
Data will be extracted from papers included in the review using the standardised data extraction tool 
from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, 
populations, study methods and outcomes of significance to the review question and specific 
objectives. 
Data synthesis 
Quantitative data will, where possible be pooled in statistical meta-analysis using JBI-MAStARI. All 
results will be subject to double data entry. Effect sizes expressed as odds ratio (for categorical data) 
and weighted mean differences (for continuous data) and their 95% confidence intervals will be 
calculated for analysis. Heterogeneity will be assessed statistically using the standard I-squared and 
tau-squared. Where possible, subgroup analyses will also be conducted based on baseline weight 
status of participants (i.e. overweight [BMI: 25-29], obese [BMI: 30-39] & morbidly obese [BMI 40+]); 
gender; age; length of study and IF approach.. Where statistical pooling is not possible the findings will 
be presented in narrative form including tables and figures to aid in data presentation where 
appropriate. 
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Appendix I: Appraisal instruments 
MAStARI Appraisal instrument 
this is a test message 
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Appendix II: Data extraction instruments 
MAStARI data extraction instrument 
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Appendix III: initial list of search terms 
 
intermittent fast* OR 
alternate-day fast* OR 
intermittent energy restriction OR  
intermittent calorie restriction OR 
fasting calorie restriction intervention OR 
intermittent restrictive diet OR 
very low calorie diet OR 
periodic fasting OR 
AND 
body mass OR 
body size OR 










Weight gain OR 
Weight maintenance OR 
Weight management OR 
AND 
adiposity OR 
adverse events OR 
bio-impedance OR 
blood glucose OR 
blood pressure OR 
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bmi OR 
bodpod OR 
body mass index OR 
cholesterol OR 
diet OR 




physical activity OR 
quality of life/QoL OR 
skin-fold/skin fold thickness OR 
waist circumference OR 
weight loss 
 
